News
Sanofi (ENXTPA:SAN) experienced a 4% decline over the past week despite a largely unchanged market. The recent events, including the FDA approval of Dupixent for a rare skin condition and the signing ...
11h
MedPage Today on MSNNovel Oral GLP-1 Agent Cuts A1c, Weight in Early DiabetesCHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...
A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...
Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.
Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry ...
Pediatric health experts call for timely vaccination and stronger public-private partnerships to combat infectious diseases ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hetronifly (serplulimab) to treat adults ...
Mid Mon Valley All Sports Hall of Fame induction ceremony was held Friday night at St. Spyridon Hellenic Center to welcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results